Cargando…

Metastasectomy of oligometastatic urothelial cancer: a single-center experience

BACKGROUND: Survival in patients with urothelial cancer (UC) recurrence after initial treatment with curative intent is limited and treatment options are sparse. Metastasectomy could be considered a treatment option in selected cases. Identifying prognostic factors for survival can be used to counse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muilwijk, Tim, Akand, Murat, Van der Aa, Frank, Dumez, Herlinde, De Meerleer, Gert, Van Raemdonck, Dirk, De Leyn, Paul, Van Poppel, Hendrik, Albersen, Maarten, Joniau, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354317/ https://www.ncbi.nlm.nih.gov/pubmed/32676413 http://dx.doi.org/10.21037/tau-19-624

Ejemplares similares

Oligometastatic prostate cancer: Metastases-directed therapy?
por: Van Poppel, Hein, et al.
Publicado: (2016)

Time to change the management of upper urinary tract urothelial carcinoma
por: Akand, Murat, et al.
Publicado: (2020)

Comparison of postoperative complications of ileal conduits versus orthotopic neobladders
por: Demaegd, Liesbeth, et al.
Publicado: (2020)

Metastasis-directed therapy for oligometastatic urological tumours: still no second-hand news
por: Berghen, Charlien, et al.
Publicado: (2020)

Comparison of Peri-operative and Early Oncological Outcomes of Robot-Assisted vs. Open Salvage Lymph Node Dissection in Recurrent Prostate Cancer
por: Devos, Gaëtan, et al.
Publicado: (2019)

Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE): a non-randomized phase 2 trial
por: Berghen, Charlien, et al.
Publicado: (2020)

The N-shaped orthotopic ileal neobladder: functional outcomes and complication rates in 119 patients
por: De Sutter, Thomas, et al.
Publicado: (2016)

Nine-year survival after iterative metastasectomies for renal cell carcinoma
por: de Oliveira, Tiago Ribeiro, et al.
Publicado: (2019)

SPARKLE: a new spark in treating oligorecurrent prostate cancer: adding systemic treatment to stereotactic body radiotherapy or metastasectomy: key to long-lasting event-free survival?
por: Rans, Kato, et al.
Publicado: (2022)

Impact of the extent of lung resection on postoperative outcomes of pulmonary metastasectomy for colorectal cancer metastases: an exploratory systematic review
por: Prisciandaro, Elena, et al.
Publicado: (2022)

Comparison of Functional Outcome after Extended versus Super-Extended Pelvic Lymph Node Dissection during Radical Prostatectomy in High-Risk Localized Prostate Cancer
por: Seikkula, Heikki, et al.
Publicado: (2017)

Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy
por: Devos, Gaëtan, et al.
Publicado: (2020)

Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Cytokeratin 5 and cytokeratin 20 inversely correlate with tumour grading in Ta non‐muscle‐invasive bladder cancer
por: Muilwijk, Tim, et al.
Publicado: (2021)

Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study
por: Kroese, Tiuri E., et al.
Publicado: (2022)

Preclinical Evidence for the Benefits of Penile Rehabilitation Therapy following Nerve-Sparing Radical Prostatectomy
por: Albersen, M., et al.
Publicado: (2008)

Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer
por: Muilwijk, Tim, et al.
Publicado: (2021)

Development of a Prospective Data Registry System for Non-muscle-Invasive Bladder Cancer Patients Incorporated in the Electronic Patient File System
por: Akand, Murat, et al.
Publicado: (2019)

Oncological and functional efficacy of nephron-sparing surgery versus radical nephrectomy in renal cell carcinoma stages ≥cT1b: a single institution, matched analysis
por: Veys, Ralf, et al.
Publicado: (2017)

Durable biochemical response following adrenal metastasectomy for oligometastatic castrate-resistant prostate cancer
por: Ashrafi, Akbar N., et al.
Publicado: (2020)

Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence (STOMP): study protocol for a randomized phase II trial
por: Decaestecker, Karel, et al.
Publicado: (2014)

Oligometastatic Melanoma Treated by Metastasectomy in Combination with Immune Checkpoint and BRAF Inhibitors: A Case Series
por: Palmer, John P., et al.
Publicado: (2023)

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
por: Decaestecker, Karel, et al.
Publicado: (2014)

Feasibility of pancreaticoduodenectomy with synchronous liver metastasectomy for oligometastatic pancreatic ductal adenocarcinoma - A case-control study
por: Shao, Yi, et al.
Publicado: (2020)

(18)F-MK-9470 PET imaging of the type 1 cannabinoid receptor in prostate carcinoma: a pilot study
por: Emonds, Kimy M, et al.
Publicado: (2013)

The potential of tumour microenvironment markers to stratify the risk of recurrence in prostate cancer patients
por: Gevaert, Thomas, et al.
Publicado: (2020)

Brain metastasis from renal urothelial carcinoma successfully treated by metastasectomy
por: Fang, Wen-Kuei, et al.
Publicado: (2018)

Double trouble for prostate cancer: synergistic action of AR blockade and PARPi in non-HRR mutated patients
por: Giesen, Alexander, et al.
Publicado: (2023)

Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter Analysis
por: Chys, Brecht, et al.
Publicado: (2020)

Evans blue-mediated white-light detection of non-muscle-invasive bladder cancer: A preclinical feasibility and safety study using a rat bladder urothelial cell carcinoma model
por: Elsen, Sanne, et al.
Publicado: (2016)

Expression of a Distinct Set of Chemokine Receptors in Adipose Tissue-Derived Stem Cells is Responsible for In Vitro Migration Toward Chemokines Appearing in the Major Pelvic Ganglion Following Cavernous Nerve Injury
por: Albersen, Maarten, et al.
Publicado: (2013)

Open and robotic radical prostatectomy
por: van Poppel, Hendrik, et al.
Publicado: (2019)

Metabolic Changes after Urinary Diversion
por: Van der Aa, Frank, et al.
Publicado: (2011)

Long-term survival of a patient with pulmonary metastatic urothelial carcinoma following metastasectomy
por: Hasebe, Kenichi, et al.
Publicado: (2018)

Survival after Metastasectomy for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis
por: Patel, Vaibhav, et al.
Publicado: (2017)

Pulmonary metastasectomy in colorectal carcinoma
por: Beckers, Paul, et al.
Publicado: (2021)

Surveillance as an Option for the Treatment of Small Renal Masses
por: Klaver, S., et al.
Publicado: (2008)

Penile metastasis in prostate cancer patients: Two case reports, surgical excision technique, and literature review
por: Landen, Lucas, et al.
Publicado: (2023)

Metastasectomy could not improve the survival of metastatic urothelial carcinoma: evidence from a meta-analysis
por: Xing, Qianwei, et al.
Publicado: (2020)

Pulmonary metastasectomy and repeat metastasectomy for colorectal pulmonary metastases: outcomes from the Dutch Lung Cancer Audit for Surgery
por: van Dorp, Martijn, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_13vl84aoc7qpp4isi4ltl7t25p